Genentech has agreed to pay a $158,208 fine to the U.S. Environmental Protection Agency (EPA) over environmental violations at its closed plant in South San Francisco. The violations discovered during a 2021 inspection include:
- Instances of improper disposal of hazardous materials.
- Unpermitted storage of waste.
- Inadequate monitoring of air emissions.
- Poor maintenance of overfill protection controls for a hazardous waste tank.
The company has implemented measures to address these issues and stated no hazardous waste emissions were identified or presented a substantial risk to human health or the environment. The South San Francisco campus, which consists of 40+ buildings, was shut down in March, with most jobs transferred to a new clinical supply center. The company is building a new $450 million plant in Oceanside, California, which is expected to be ready by 2024.
To read more, click here.
[Source: Fierce Pharma, August 10th, 2023]